NRAV and hepatocellular carcinoma: We demonstrated that the overexpression of NRAV inhibits the β-catenin to p-β-catenin ratio in HCC cells, whereas the silencing of NRAV markedly enhances the p-β-catenin to β-catenin ratio (Figures 6A–6c).